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US22 gene family members m142 and m143 are essential for replication of murine cytomegalovirus (MCMV). Their transcripts are
produced with immediate-early kinetics, but little else is known about these viral genes. Unlike their transcripts, the m142 and m143 gene
products (pm142, pm143) were not expressed until early times post-infection, with levels increasing over the course of infection. Both pm142
and pm143 were predominantly cytoplasmic, but cellular fractionation studies confirmed that the proteins were present in the nucleus as well.
In addition, pm142 was detected within the virion. Both the m142 and m143 promoters were strongly upregulated by viral infection or by
MCMV IE1. However, UV-inactivated virus and IE3 upregulated only the m142 promoter. When tested for transcriptional transactivating
activity, neither m142 nor m143 demonstrated significant activity, either alone or in combination with the major immediate-early gene
products. This failure to transactivate, along with their essential nature, makes m142 and m143 unique among the immediate-early genes of
the US22 gene family.
D 2005 Elsevier Inc. All rights reserved.
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Recently, two novel immediate-early murine cytomega-
lovirus (MCMV) genes, m142 and m143, were identified
(Hanson et al., 1999a) and later found to be essential for
virus replication (Menard et al., 2003). Little else is known
about these genes, other than that they are members of the
US22 gene family (Rawlinson et al., 1996).
The US22 multigene family was first described for
human cytomegalovirus (HCMV) (Chee et al., 1990), and is
conserved in all of the h-herpesviruses, with several0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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campbeae@evms.edu (A.E. Campbell).members of the family found in each virus (Chee et al.,
1990; Gompels and Macaulay, 1995; Nicholas, 1996;
Rawlinson et al., 1996). The US22 gene family is
characterized by the presence of one or more of four
conserved motifs (Chee et al., 1990; Efstathiou et al., 1992;
Nicholas, 1996). US22 family members can be divided by
kinetics of expression, being transcribed with either
immediate-early (IE) or early (E) kinetics (Colberg-Poley
et al., 1992; Hanson et al., 1999a; Romanowski and Shenk,
1997; Stasiak and Mocarski, 1992).
A wide variety of functions have been reported for
members of the US22 gene family. Some members of this
gene family act as transcriptional transactivators in
transient transfection assays (Cardin et al., 1995; Flebbe-
Rehwaldt et al., 2000; Kashanchi et al., 1994, 1997; Mori
et al., 1998; Romanowski and Shenk, 1997). However, the
importance of this activity in viral infection is less clear.
The IE2 gene product, for example, is dispensable for05) 166–177YVIRO-02961; No. of pages: 12; 4C: 5, 6
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and Mocarski, 1988), and in vivo (Cardin et al., 1995).
Similarly, deletion of HCMV IRS1 has no impact upon
viral replication in vitro (Blankenship and Shenk, 2002;
Jones and Muzithras, 1992). Deletion of TRS1 on the
other hand results in an attenuated virus (Blankenship and
Shenk, 2002). The impairment in the TRS1 mutant is due
to a viral assembly defect (Adamo et al., 2004), while
accumulation of viral mRNAs from cells infected with the
TRS1 mutant is generally similar to that seen in the non-
attenuated IRS1 mutant (Blankenship and Shenk, 2002).
Although not all viral transcripts were examined, these
results suggest that TRS1 may not serve solely as a
transcriptional transactivator in the context of viral
infection. Since many of the US22 gene products reported
to be transcriptional transactivators are predominantly
cytoplasmic, it is possible that the apparent transcriptional
transactivation activity is an indirect effect. The recent
findings by Child et al. (2002, 2004) that IRS1 or TRS1
can substitute for vaccinia virus ds-RNA binding protein
E3L suggests that IRS1/TRS1 might have RNA binding
abilities, perhaps resulting in increased translation rather
than transcription. These results support the hypothesis that
TRS1 mediates multiple functions in the infected cell to
enhance the efficiency of viral replication.
Other members of the US22 gene family are also
important for optimal viral replication. MCMV gene M43
is necessary for efficient replication in several cell types in
vitro (Menard et al., 2003) and in the salivary gland in
vivo (Xiao et al., 2000). M139, M140, and M141 mediate
efficient replication in macrophages (Cavanaugh et al.,
1996; Hanson et al., 1999b, 2001; Menard et al., 2003),
and are important for replication in the spleen, but not the
liver in vivo (Hanson et al., 1999b, 2001). Deletion of
HCMV US22 family genes UL28, UL29, US23, US24,
and US26 results in attenuated growth in human foreskin
fibroblasts (Dunn et al., 2003; Yu et al., 2003), while
UL24 deletion results in impairment in human micro-
vascular endothelial cells (Dunn et al., 2003). Although
the mechanism for the impairment from deletion of US22
family genes is generally unknown, HCMV UL36 and the
MCMV homologue M36 enhance viral replication by
inhibiting apoptosis in infected cells (McCormick et al.,
2003; Menard et al., 2003; Skaletskaya et al., 2001).
Thus, many of the members of this gene family are non-
essential for viral replication, but serve to enhance
replicative ability, sometimes in a cell type or organ-
specific fashion.
Finally, several of the members of the US22 gene
family in HCMV have been reported to be virion
components, including UL23, UL24, UL43, US22,
IRS1, and TRS1 (Adair et al., 2002; Romanowski et al.,
1997). The importance of the presence of these proteins in
the virion is unclear, since none of them is essential
(Blankenship and Shenk, 2002; Dunn et al., 2003; Yu
et al., 2003).The only essential members of this gene family reported
to date are m142 and m143. When the sequence of the
m142 and m143 genes are compared to HCMV ORFs, the
most homologous genes are US26 and US23, respectively
(Rawlinson et al., 1996). However, when we scanned the
MCMV genome for homologues of HCMV US22 family
genes IRS1 or TRS1, the closest homologues were m142
and m143. There are additional characteristics supporting
the possibility that m142 and/or m143 are the functional
homologues for HCMV IRS1 and TRS1. First is the fact
that m142 and m143 lack US22 motif II, which is present
in all of the other MCMV US22 family members, but is
lacking in IRS1/TRS1 (Chee et al., 1990; Rawlinson et al.,
1996). Additionally, m142 and m143 are transcribed with
immediate-early kinetics (Hanson et al., 1999a), as are
IRS1 and TRS1 (Romanowski and Shenk, 1997; Stasiak
and Mocarski, 1992). Finally, although either IRS1 or
TRS1 can be singly deleted from HCMV, no one has yet
deleted both genes. Since IRS1 and TRS1 are highly
homologous, differing only at their C terminal ends
(Weston and Barrell, 1986), and the presence of at least
one is essential for viral DNA replication in transient
assays (Pari and Anders, 1993; Pari et al., 1993), it is
possible that they perform an essential function for which
either one alone is sufficient. Whether m142 and m143
have similarities to IRS1 and TRS1 in other characteristics
such as intracellular localization, incorporation into the
virion, or transcriptional transactivational activity have not
been explored.
In this study, we set out to characterize the protein
products of m142 and m143 and perform an initial assess-
ment of their regulation by cellular and viral factors. In
contrast to their immediate-early transcription pattern,
pm142 and pm143 are expressed with early kinetics, as
revealed by sensitivity to cycloheximide. Both proteins
products were detectable by 3 h post-infection and
continued to increase throughout the course of infection.
At both early and late times, pm142 and pm143 were
diffusely localized in the cytoplasm with a low level of
nuclear staining. The two proteins co-localized in the
cytoplasm in co-transfected cells. The m142, but not the
m143, gene product was also detected in purified virion
preparations, suggesting that pm142 may be a tegument
component. Both the m142 and m143 promoters were
upregulated by viral infection, and by MCMV IE1 or IE1
and IE3, consistent with their immediate-early kinetics.
However, only the m142 promoter was significantly
activated by treatment with UV- inactivated virus or IE3
alone. When tested for transcriptional transactivating
activity, no significant activation was detected on either
the MCMV major immediate-early promoter or the e1
promoter by m142 or m143, either alone or in combination
with IE1 and IE3. Thus, although the expression patterns,
both in kinetics and localization, of pm142 and pm143 are
similar to IRS1 and TRS1 proteins, the similarity is not
complete, at least at the functional level.
Fig. 2. Lack of expression of pm142 and pm143 under immediate-early
conditions. NIH3T3 cells were infected as described for Fig. 1, except that,
where indicated, the cells were treated with 100 Ag/ml cycloheximide for 1 h
prior to infection and the first 4 h of the infection, followed by removal of
the cycloheximide and treatment for 3 h with 10 Ag/ml Actinomycin D. The
cells were harvested using the NE-PER kit, as this allows a more
concentrated protein yield. Cytoplasmic (C) and nuclear (N) fractions were
analyzed by Western blot analysis using polyclonal antisera for the
indicated proteins. The blot was also analyzed for expression of the
immediate-early protein pp89 as a positive control.
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Characterization of m142 and m143 proteins in MCMV-
infected cells.
We investigated the expression of the m142 and m143
protein products by Western blot analysis, assessing size and
kinetics (Fig. 1). One protein of 43 kDa was recognized in
infected cell lysates by the m142-specific rabbit polyclonal
antiserum (Fig. 1A). The other apparent viral specific bands
seen on this blot were not consistently detected, and were
only seen with antisera from one of two immunized rabbits.
Similarly, a single protein of 53 kDa was recognized by the
m143-specific antisera (Fig. 1A). Both proteins were readily
detectable by 6 h post-infection, and levels increased over
the course of infection (Fig. 1B). Although not evident in
this blot, in other experiments both proteins were detected
by 3 h post-infection (for example, see Fig. 4). By Western
blot analysis, both pm142 and pm143 were significantly
smaller than the predicted sizes of 49 and 64 kDa,
respectively. In order to confirm that the antibodies were
recognizing the correct proteins, they were tested on lysates
from cells transfected with plasmids expressing either m143
or m142 (Fig. 1C). Proteins of the same size were
recognized from the transfected cells, confirming the
specificity of the antisera.
Both m142 and m143 are transcribed with immediate-
early kinetics (Hanson et al., 1999a); however, the protein
expression was not readily apparent at immediate-earlyFig. 1. Characterization of m142 and m143 protein products. Monolayers of
NIH3T3 fibroblasts were infected with 2 PFU of MCMV per cell. Cell
lysates were harvested and equal volumes of lysates were electrophoresed
on a 12.5% acrylamide gel for Western blot analysis. M, mock-infected
cells. I, infected cells. (A) Identification of pm142 and pm143 in MCMV-
infected cells. Lysates from infected or mock-infected cells were harvested
at 24 h post-infection. Western blots were probed with the indicated rabbit
polyclonal antisera, a142, anti-m142 antibody, a143, anti-m143 antibody.
(B) Kinetics of pm142 and pm143 expression. Cell lysates were harvested
at the indicated hours post-infection. The blot was probed with a mixture of
m142 and m143 specific antisera. (C) Expression plasmids produce the
same products as found in infected cells. NIH3T3 fibroblasts were
transfected with expression plasmids p142 or p143. Lysates were harvested
and subjected to Western blot analysis along with mock and 24 h infected
cell lysates. The blot was probed as in B.times. Thus, we assessed the expression of pm142 and
pm143 after treatment with cycloheximide followed by
actinomycin D (Fig. 2). Neither pm142 nor pm143 were
expressed at detectable levels under these conditions,
whereas the major immediate-early protein pp89 was readily
detectable.
Regulation of m142 and m143 promoters
Since m142 and m143 were previously found to be
transcribed with immediate-early kinetics (Hanson et al.,
1999a), but the proteins were not detectable under
immediate-early conditions, we performed a preliminary
promoter analysis for m142 and m143. As expected for ie
genes, the putative promoter regions of both m142 and
m143 had significant basal activity above that of the
empty vector in mock-infected cells, 130-fold and 34-
fold, respectively (Fig. 3A). Infection with MCMV
enhanced the activity of both promoters (Fig. 3B).
However, exposure of the transfected cells to UV-
inactivated MCMV resulted in moderately increased acti-
vity of only the m142 promoter. Thus, although cellular
transcription factors are capable of activating the m142
and m143 promoters, optimal activation requires viral
gene products, or cellular gene products induced upon
viral infection.
Likely viral candidates for transactivation of the m142
and m143 promoters during MCMV infection are the
MCMV major immediate-early proteins IE1 and IE3, the
products of gene m123. Analysis of the ability of IE1
and/or IE3 to activate the m142 and m143 promoters
demonstrated that IE1 alone was sufficient to enhance
activation of the m143 promoter. In contrast, both IE1
and IE3 were required to fully activate the m142
promoter (Fig. 3C). In all cases, the m142 promoter
resulted in higher luciferase activity than the m143
promoter.
Fig. 3. Activation of the m142 and m143 promoters in transfected NIH3T3
fibroblasts. NIH3T3 cells were transfected with reporter plasmids 142pluc,
143pluc, or the parental pxp2, split the next day, and infected or mock
infected 24 h after splitting. Lysates were harvested 24 h later in
Luciferase Reporter Buffer and luciferase production was assayed. The
assay was repeated at least three times and the mean and standard
deviation from three replicate experiments are shown. The reporter
plasmids 142pluc and 143pluc contain the upstream sequences from
823 to +95 and 832 to +7 relative to the cap sites, respectively. (A)
Basal levels compared to the parental pxp2 vector. (B) Activation by WT
or UV-inactivated MCMV. Transfected cells were infected with an MOI of
5 PFU/cell. Cells treated with UV-inactivated virus received an equal
volume of virus from the same preparation which had been UV-
inactivated. (C) Activation of the m142 and m143 promoters by IE1
and IE3. NIH3T3 cells were co-transfected with 142luc or 143luc and
plasmids expressing IE1, IE3, or both (indicated as 1+3). Control cells
were co-transfected with the parental vector pucHH. All transfected cells
that were not infected were mock infected to allow comparison with
infection. Replicate plates were transfected and superinfected with 5 PFU/
cell of MCMV.
Fig. 4. Subcellular localization of m142 and m143 proteins by fractionation.
Monolayers of NIH3T3 fibroblasts were infected as described in the legend
to Fig. 1. Cells were harvested 3 or 24 h post-infection and the cytoplasmic
(C) and nuclear (N) fractions were prepared using the NE-PER kit.
Cytoplasmic and nuclear extracts representing equal numbers of cells were
analyzed by Western blot analysis using polyclonal antisera specific for the
indicated proteins. Antibodies specific for the cellular cytoplasmic protein
PTP-PEST (PTP) and the endoplasmic reticulum-resident protein calnexin
were included to demonstrate the purity of the nuclear fractions. M, extracts
from mock-infected cell.
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Other US22 family members localize to both the
nucleus and cytoplasm of infected cells, and the local-
ization may change over the course of infection (Mocarski
et al., 1988; Mori et al., 1998; Romanowski and Shenk,
1997). Localization of pm142 and pm143 was assessed intwo ways, by cell fractionation and by confocal micro-
scopy. Mock-infected or infected NIH3T3 fibroblasts were
divided into cytoplasmic and nuclear fractions and the
lysates were analyzed by Western blot analysis. Both
pm142 and pm143 were detected in both fractions at early
and late times post-infection (Fig. 4). The samples were
also probed with antisera specific for protein tyrosine
phosphatase-PEST (PTP-PEST) and calnexin to confirm
lack of cytoplasmic contamination of the nuclear fraction,
even by membrane-associated cytoplasmic proteins.
Although amounts of nuclear and cytoplasmic lysates
corresponding to an equal number of cells were used, this
Western blot analysis is not truly quantitative. Thus,
immunofluorescent localization by confocal microscopy
was performed upon infected cells.
Confocal analysis of cells at late times showed that both
pm142 and pm143 were predominantly diffusely localized
in the cytoplasm (Fig. 5A). Cells fixed at early times in
infection showed very similar localization patterns (Fig.
5B). Although the proteins were predominantly cytoplas-
mic, there was some nuclear staining, and the localization
of the two proteins in the nucleus was different. While
pm142 was readily detected in the nuclei of most infected
cells, nuclear staining for pm143 was more variable, with
some cells displaying a punctate staining pattern, while
others had little or no detectable nuclear pm143. Macro-
phages (IC-21 cells) were used for these experiments
because the minimal CPE makes intracellular localization
easier to discern in the infected cells. However, the same
localization patterns were seen in infected NIH3T3
fibroblasts (data not shown). For both pm142 and
pm143, the nuclear staining did not generally correlate
with areas of accumulation of M44 (data not shown),
suggesting that they are not associated with viral repli-
cation compartments.
Fig. 5. Immunofluorescent localization of pm142 and pm143 in infected cells. Subconfluent monolayers of IC-21 macrophages were infected at 5 PFU per cell
with MCMV. Cells were fixed at the indicated times post-infection and localization was determined using the specified antiserum and FITC goat-anti-rabbit
IgG. Maximum projections from a z series generated using the Zeiss510 confocal microscope at 40 are shown in each case. The gain was set to the optimal
for detection at 24 h post-infection in all cases. (A) Mock-infected and infected cells at late times (24 h) post-infection. The infected cells stained with rabbit
pre-immune serum (NRS) were costained with mouse anti-M44 and TRITC goat-anti-mouse IgG to confirm that they were infected. (B) Localization at early
times post-infection. The cells were examined at 40 with a 2 zoom.
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inherent to the proteins, or dependent upon other viral
factors, transiently transfected NIH3T3 fibroblasts were
examined by confocal microscopy (Fig. 6). This study also
allowed us to assess whether or not the similar cytoplasmic
staining patterns for pm142 and pm143 reflected co-local-
ization. When transfected alone, pm142 displayed the same
nuclear and cytoplasmic localization as seen in infected cells
(Fig. 6B). However, no nuclear staining was detected for
pm143 in the transient transfections (Fig. 6C). When trans-
fected together, pm142 and pm143 co-localized in the
cytoplasm (Fig. 6D). There is no cross-reactivity between
the anti-serum for the two proteins (Fig. 6A and data not
shown) indicating that this is truly co-localization. Interest-ingly, in the cotransfected cells the faintly staining nuclear
pm142 appeared to be condensed, as opposed to the fairly
diffuse nuclear staining in infected cells or when m142 was
transfected alone.
Since pm142 and pm143 were diffusely cytoplasmic, we
investigated whether they co-localized with calnexin or
GS28 as markers for the endoplasmic reticulum and cis-
Golgi, respectively (Fig. 6E). There was no significant co-
localization with either marker. Similarly, m142 and m143
did not co-localize with wheat germ agglutinin, a marker for
trans-Golgi (data not shown). Thus, pm142 and pm143
appear to be truly cytoplasmic.
Several of the members of the US22 gene family in
HCMV have been reported to be virion components,
Fig. 6. Immunofluorescence localization of pm142 and pm143 in transiently transfected cells. NIH3T3 fibroblasts were transfected with plasmids p142, p143,
or cotransfected with plasmids p142 and GFP143. Forty-eight hours after transfection the cells were fixed and stained with the indicated antibodies (a142, anti-
m142 antibody, a143, anti-m143 antibody, aGS28, anti-GS28 antibody, acalnexin, anti-calnexin antibody, NRS, normal rabbit serum, NMS, isotype-matched
mouse monoclonal antibody) followed by AlexaFluor 647 goat-anti-rabbit IgG and TRITC goat-anti-mouse IgG. Confocal microscopy was performed as in
Fig. 5B. (A) Cells transfected with p143 and stained with anti-m142 antiserum. (B) Cells transfected with p142 and stained with anti-m142 antiserum. (C) Cells
transfected with p143 and stained with anti-m143 antiserum. (D) Colocalization of m142 and m143. Cells were cotransfected with GFP143 and p142 and
stained with anti-m142 antiserum. (E) Subcellular localization of m143. Cells were transfected with GFP or the GFP143 fusion construct and stained for the ER
marker calnexin and the cis-Golgi marker GS28. Control cells were transfected with GFP alone and stained with pre-immune rabbit serum (NRS) and control
mouse antibody (NMS) to demonstrate specificity of the staining.
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(Adair et al., 2002; Romanowski et al., 1997). Therefore,
we performed Western blot analysis on sucrose gradient
centrifugation purified virion preparations, screening for
the presence of pm142 and pm143 (Fig. 7A). Low levels
of pm142, but not pm143, were detected in the virion
preparations. Since pm142 and pm143 are expressed at
similar levels in the same location in infected cells, the
failure to detect pm143 in the virion preparations
suggested that the detection of pm142 is not due solely
to contamination of the viral preparation. In order to
determine whether the pm142 detected in the virion
preparation was truly a virion component, samples were
subjected to trypsin treatment in the presence or absence of
1% Triton X-100 and analyzed by Western blot analysis
(Fig. 7B). The data show that pm142 was digested by
trypsin only upon co-treatment with detergent, whichallowed for disruption of the viral envelope. The blot
was stripped and reprobed for the MCMV tegument
protein M25 which exhibited the same pattern of protec-
tion, although the staining was much stronger. These
results confirm that pm142 is probably a low abundance
virion component.
Transcriptional activation by pm142 and pm143
Some immediate-early US22 gene family members have
transcriptional transactivation activity in transient assays, in
spite of their predominantly cytoplasmic localization. These
include HCMV IRS1 and TRS1 (Romanowski and Shenk,
1997) and HHV-6 U3 ((Mori et al., 1998). However, neither
pm142 nor pm143 demonstrated any significant transactiva-
tional activity upon either the MCMV MIEP (UL123) or the
early e1 (UL112/113) promoter when tested either alone or
Fig. 7. Analysis of virions for presence of pm142 and pm143. MCMV
virion fractions were prepared by centrifugation through sucrose gradients.
Eighteen micrograms of total virions was subjected to polyacrylamide gel
electrophoresis along with 24 h post-infection mock and infected cell
lysates prepared as described for Fig. 1. (A) Western blot analysis of virion
preparations for m142 and m143. Western blot analysis was performed
using a mixture of m142 and m143 antisera. M, mock-infected cell lysate, I,
infected cell lysate, V, purified virions. (B) Western blot analysis of trypsin
treated virions. Eighteen micrograms of total virions were incubated at
37 8C for 3 h in PBS (V), in PBS with 90 Ag/ml trypsin (VT) or in PBS with
trypsin and 1% Triton X-100 (VTT) before PAGE and Western blot analysis
with anti-m142 antiserum. M and I indicate cell lysates as in Fig. 5A. The
blot was re-probed with a mouse monoclonal antibody specific for M25 to
demonstrate the specificity of the trypsin treatments.
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products (Fig. 8).Fig. 8. Promoter regulation by pm142 and pm143 in transfected NIH3T3
fibroblasts. NIH3T3 cells were transfected as described for Fig. 3. Cell
lysates were harvested 48 h post-transfection and CAT assays were
performed by standard methods, using 20 Al of extract. After auto-
radiography, quantitation was performed using Phosphorimager analysis
and the results were corrected for relative protein levels. The plasmids
expressing pm142 and pm143 are designated p142 and p143, pcD is the
parental empty pcDNA3 vector and p142/3 indicates transfection with both
pm142 and pm143. The plasmids expressing the major immediate-early
proteins are as in Fig. 3; these were used at a concentration sub-optimal for
activation, to allow demonstration of enhancement. (A) Activation of the
m123 major immediate-early promoter. Cells were transfected with a
plasmid containing the CAT gene under the control of the MCMV major
immediate-early promoter along with the indicated constructs. (B)
Activation of the M112/113 promoter. Cells were transfected with a
plasmid containing the CAT gene under the control of the MCMV M112/
113 (e1) promoter along with the indicated constructs.Discussion
Previously, we hypothesized that MCMV m142 and/or
m143 might be the MCMV homologues of HCMV IRS1/
TRS1 (Hanson et al., 1999a), based on the facts that: (1)
when the MCMV genome was screened for homologues to
IRS1 and TRS1 the most homologous genes were m142 and
m143; (2) like IRS1 and TRS1, m142 and m143 lack US22
motif II, which is present in all other MCMV US22 gene
family members; and (3) the immediate-early transcription
patterns of IRS1/TRS1 and m142 and m143 are similar. Our
data on the kinetics of m142 and m143 protein expression
and the localization are similar to those of IRS1 and TRS1.
In addition, m142 is a virion component, like IRS1 and
TRS1. Nonetheless, the failure of m142 and m143 to
significantly enhance the transcriptional transactivation of
the UL112/113 promoter does not support a functional
homology. However, IRS1 and TRS1 mediate other
functions, such as inhibition of the ds RNA response
pathway (Child et al., 2002, 2004), which have yet to be
investigated for m142 and m143.
Despite the similarities to IRS1/TRS1, when screening
the HCMV genome for homologies to m142 and m143, the
closest homologues are US26 and US23, respectively(Rawlinson et al., 1996). Neither of these genes is essential,
although deletion of either results in an attenuated pheno-
type (Dunn et al., 2003; Yu et al., 2003). The kinetics,
localization, and functions of these gene products have not
been analyzed. Such studies will help to clarify the
functional homologies between the US22 gene family
members in the two viruses.
Like IRS1 and TRS1, m142 and m143 are transcribed
with immediate-early kinetics (Hanson et al., 1999a).
However, the m142 and m143 proteins are expressed with
early kinetics. In this regard, their expression is like that of
IRS1, with mRNA produced in the presence of cyclo-
heximide, but no protein is detectable when the cells are
infected in the presence of cycloheximide followed by
treatment with actinomycin D (Romanowski and Shenk,
1997). This suggests that there is some additional regulation
of these gene products at the translational or post-transla-
tional level. The fact that both the m142 and m143 promotor
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such regulation is at a post-transcriptional level.
The intracellular staining patterns of pm142 and pm143
are interesting, since pm142 is detectable in the nucleus even
in the absence of other viral proteins, whereas pm143, which
has a consensus nuclear localization signal, is only detected
in the nucleus in the context of viral infection. The nuclear
staining pattern for pm143 was not consistent, being seen in
some cells, and even only in some nuclei in the same
multinucleated cell. Both proteins were predominantly
cytoplasmic, and they did not co-localize with markers for
either the ER or Golgi. This is not unexpected, as neither
protein is predicted to be membrane-associated by sequence
analysis. The predominantly cytoplasmic staining pattern
was in marked contrast to the results found with cell
fractionation, where both proteins were found abundantly
in both the nuclear and cytoplasmic fractions. There are
several possible explanations for this discrepancy. The fact
that infected nuclei were positive for M44 indicated that the
m143 staining pattern was not due to lack of permeabiliza-
tion of the nuclear membrane. However, the very intense
cytoplasmic staining could make it difficult to detect a low
level of nuclear staining. It is also possible that there was
contamination of the nuclear fraction in the cell fractionation
experiments, despite the low levels indicated by the control
antibody. It should also be remembered that the Western blot
analysis in this case is not truly quantitative. Although
proportional volumes of lysates from the cytoplasmic and
nuclear fractions were used, reflecting equal numbers of
cells, if the nuclear lysis was more efficient this could
explain the apparent relative abundance of the proteins in this
fraction compared to the cytoplasmic fraction.
There were several intriguing results from the evaluation
of activation of the m142 and m143 promoters. As
expected, since m142 and m143 are transcribed with
immediate-early kinetics, both promoters were active in
non-infected cells. In addition, both promoters were
upregulated by viral infection, while UV-inactivated virus
only upregulated the m142 promoter, albeit weakly. Thus,
neither virion components nor cellular factors, which are
upregulated upon viral binding, appear to be major players
in the regulation of m142 and m143. However, since the
m142 promoter is slightly activated by treatment of cells
with UV-inactivated virus, identification of the cellular
genes which are upregulated in response to UV-inactivated
MCMV may help to determine the cellular transcription
factors important for regulation of this promoter.
Since optimal activation of both the m142 and m143
promoters required viral gene expression, we assessed the
activation by the major immediate-early products, IE1 and
IE3. Because the major immediate-early proteins of HCMV
increase the expression of the HCMV immediate-early
IRS1263 promoter (Romanowski and Shenk, 1997), it was
logical to examine the effects of IE1 and IE3 on the m142
and m143 promoters. The results for the m142 promoter, in
which either of the major immediate-early proteins activatedthe promoter, was very similar to what was found for
IRS1263. Regulation of the m143 promoter, in which IE1,
but not IE3, activated is different than either of these.
Analysis of the putative m142 and m143 promoter regions
indicated the presence of a number of potential transcrip-
tional activator binding sites. Both promoters contain three
or more ATF/CREB consensus binding motifs. These are
likely to be important for the regulation of these genes as
ATF/CREB sites are important for activation of a number of
cytomegaloviral promoters (Chau et al., 1999; Meier et al.,
2002; Rodems et al., 1998; Schwartz et al., 1996) and can
play a role in the transactivation mediated by IE1 (Lang et
al., 1995). Both promoters also contain one or more
potential AP2 binding sites. It is intriguing that the R3
enhancer region for the HHV-6 immediate-early U95 gene,
also a member of the US22 gene family, contains multiple
putative AP2 binding sites (Takemoto et al., 2001). There
are also some sites which may be important for the
differential regulation of the m142 and m143 immediate-
early promoters. For example, the m142 promoter contains
four putative SP1 binding sites, while the m143 promoter
region contains only one, and this is over 650 bases
upstream of the cap site. The SP1 sites are particularly
noteworthy since the major immediate-early proteins induce
and enhance activation by SP1 (Yurochko et al., 1997). Also
of note is the presence of a consensus EGR1 recognition site
in the m142 promoter, since the HCMV IE2 protein (the
homologue of the MCMV IE3 protein) has been reported to
activate TGF-h via interactions with EGR1 (Yoo et al.,
1996). Further studies on the sequences important for
regulation of these promoters are needed.
In our studies, IE1 or the co-expressed IE1 and IE3
activated the m142 and m143 promoters to a greater extent
that did viral infection. Although this may merely reflect the
fact that the IE proteins are continuously highly expressed in
the transiently transfected cells, while the levels decrease
during early times of infection (Messerle et al., 1992), it also
may indicate some repressive factors, either viral gene
products or cellular proteins induced by viral infection.
Preliminary studies using PFA to prevent late gene
expression show a higher level of activation of both
promoters in the presence of PFA, correlating with an
increased level of IE1 protein by Western blot analysis
(unpublished data). Further experiments to determine the
importance of IE1 versus other viral factors are needed to
answer this question.
Unlike several other members of the US22 gene family,
m142 and m143 had no significant transcriptional trans-
activating activity on the immediate-early or early promoters
tested. This correlates well with the predominantly cyto-
plasmic localization of the proteins, although some of the
US22 gene products reported to be transcriptional trans-
activators are primarily cytoplasmic, with little or no nuclear
localization (Mori et al., 1998; Romanowski and Shenk,
1997). In light of recent findings of other functions for
putative transcriptional transactivators, for example, the
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al., 1999; Skaletskaya et al., 2001), the inhibition of
antiviral pathways by IRS1 and TRS1 (Child et al., 2004)
and the late defect in TRS1 deletion mutants (Blankenship
and Shenk, 2002), these should be productive areas to
research for the essential function or functions mediated by
m142 and m143.Material and methods
Cells and viruses
Murine NIH3T3 fibroblasts [America Type Culture
Collection (ATCC) CRL-1658, Rockville, MD] were
propagated in Dulbecco’s modified Eagle’s medium
(DMEM, Mediatech, Herndon, VA) supplemented with
10% heat-inactivated BCS (Hyclone Laboratories, Logan,
UT) and 1% l-glutamine (GIBCO BRL, Grand Island,
NY). IC-21 murine macrophages (ATCC TIB 186) were
propagated in RPMI medium (Mediatech) supplemented
with 10% heat-inactivated FCS (GIBCO BRL) and 1% L-
glutamine. The virus used in these studies was MCMV
Smith strain (ATCC VR 194). All virus stocks were
propagated in NIH3T3 fibroblasts and quantified by
standard plaque assay. Mock virus preparations were
supernatants from uninfected NIH3T3 fibroblasts. For
certain experiments virus was UV-inactivated by exposure
to a 35-W UV light source for 45 min on ice at a
distance of 16 cm. A decrease in titer of greater than four
logs was confirmed by plaque assay of the UV-inactivated
virus.
Plasmids
The plasmid pZeo-I, containing genes m142 and m143,
was made by inserting the BsrG1 fragment of HindIII I
(bases 203538 to 198878) into the Acc65I site of pSVZeo
(Invitrogen, Carlsbad, CA). Plasmids for bacterial expres-
sion of recombinant His-tagged m142 and m143 were
generated using the pBad system (Invitrogen). For m142 a
Kpn1–EcoRI fragment (bases 200531 to 198303) from
pZeo-I lacking the N-terminal 217 base pairs (bp) of m142
was cloned into pBad/HisA resulting in pBad142. For m143
a Kpn1 fragment from pZeo-I containing bases 202427 to
200531, and lacking 166 bp from the N-terminal end of
m143 was cloned into pBad/His A to produce the plasmid
pBad143.
Plasmids for mammalian expression of m142 and m143
were generated in pCDNA3.1 (Invitrogen). The genes were
cloned by PCR using primers for m142 (5V-TCTCCAC-
CCGAATTCCCGCTGCCG-3V forward and 5V-CGA-
GGCGATATCCCGTCCGTCCGTC-3V reverse) and m143
(5V-TCCGCTCGAATTCGTCCGCCCGTC-3V forward and
5V-GGGCGGGTGATATCAGAGATGACATG-3V reverse)
between the EcoRI and EcoRV sites in the vector. Thisresulted in plasmids p142 and p143. The plasmid GFP143,
expressing a green fluorescent protein–m143 fusion product
was generated in the vector pEGFP-C1 (Clontech, Palo
Alto, CA). A BglII fragment containing MCMV sequence
from base 202660 to 201714 was inserted into the BglII site
of pEGFP-C1. Secondly, an SstI–PstI fragment containing
MCMV bases 201739 to 200635 was inserted, producing a
construct in which the entire m143 open reading frame, plus
67 bases upstream which are normally non-coding, was
expressed as a fusion with GFP. A protein of the expected
size was recognized by m143-specific antiserum confirming
the proper construct (data not shown).
Luciferase reporter plasmids 142pluc and 143pluc were
generated in the plasmid PXP2 (Nordeen, 1988) by cloning
the HindIII fragments generated from PCR using primers 5V-
GGAGCTAAGCTTCCACTCCCGAG-3V forward and 5V-
TGATCCGAAAGCTTCGCCGCGCAC-3V reverse for
142pluc (917 bp fragment) and 5V-GACGGCAAGCT-
TACCGAGGATG-3V forward and 5V-CTCCGGTCAAGC-
TTGAGATCGCG-3Vreverse for 143pluc (928 bp fragment).
The m142 and m143 start codons were subsequently
removed. For 142pluc the NcoI site containing the m142
start codon was destroyed using S1 nuclease (Promega),
resulting in removal of the ATG. For 143pluc the plasmid
was digested with BglII and religated, deleting everything
immediately down-stream of the previously identified cap
site (Hanson et al., 1999a).
Plasmids encoding MCMV immediate-early genes and
the ie and e1 CAT reporter constructs were kindly provided
by Dr. Martin Messerle (University of Halle, Halle,
Germany). These include plasmids pp89UC, pIE3, and
pIE111 which encode the MCMV immediate-early proteins
IE1, IE3, and IE1+IE3, respectively, as well as the MCMV
MIEP (m123) CAT construct pMCMV3CAT, and the m112/
113 (e1) promoter CAT construct (Messerle et al., 1992). To
avoid possible confusion, we refer to plasmid pIE111 as
pIE1+3 in this paper.
Antibodies
Recombinant His-tagged m142 and m143 were gener-
ated from the plasmids pBad142 and pBad143 by
induction with 0.2% and 0.02% arabinose, respectively.
The His-tagged proteins were solubilized and extracted
with B-PER and solubilizing reagent (Pierce, Rockford,
IL). The proteins were purified using the Xpress system
(Invitrogen) under denaturing conditions according to the
manufacturer’s directions. The recombinant proteins were
used to generate rabbit polyclonal antisera (Cocalico,
Reamstown, PA).
The MCMV M44 and M25 monoclonal antibodies were
generous gifts from Drs. Carol Wu and John Shanley
(University of Connecticut, Farmington, CT). Protein
tyrosine phosphatase (PTP)-PEST-specific antiserum, a
positive control for cytoplasmic specificity (Charest et al.,
1995), was the generous gift of Dr. Michael Tremblay
L.K. Hanson et al. / Virology 334 (2005) 166–177 175(McGill University, Montreal, Quebec, Canada). The anti-
body to pp89 was a generous gift from Dr. Ulrich
Koszinowski (Max von Pettenkofer Institute, Munich,
Germany). The mouse anti-calnexin antibody was pur-
chased from BD Biosciences (San Jose, CA). The rabbit
anti-calnexin antisera was purchased from Stressgen (Vic-
toria, BC, Canada). Production of the rabbit antisera specific
for M112/113 (e1) has been previously published (Ciocco-
Schmitt et al., 2002).
Western blot analysis of viral gene expression
Expression of the m142 and m143 gene products was
monitored by Western blot analysis as previously described
for m141 (Hanson et al., 2001).
For intracellular localization of viral proteins, cell
fractionation was performed using the NE-PER kit (Pierce)
according to the manufacturer’s directions. Volumes of
cytoplasmic and nuclear fractions representing equivalent
numbers of infected cells were electrophoresed on 12.5%
acrylamide gels and blotted as described (Hanson et al.,
2001). For analysis of immediate-early protein kinetics,
NIH3T3 cells were treated with 100 Ag/ml cycloheximide
(Sigma-Aldrich, St. Louis, MO) for 1 h prior to infection,
during the infection, and for 3 h after infection. After 3 h,
the cycloheximide was removed with three washes with
PBS and the cells were incubated for an additional 4 h in the
presence of 10 Ag/ml of the transcriptional inhibitor actino-
mycin D (Sigma-Aldrich) before harvesting using the NE-
Per kit.
For examination of virion composition, virus was
purified by gradient centrifugation on a 20 to 70%
sorbitol gradient as previously described (Hanson et al.,
2001). Total protein in the virion preparation was
determined using the Coomassie Plus 200 protein assay
reagent (Pierce) according to manufacturer’s instructions.
Eighteen micrograms each of total virion protein was
subjected to treatment with 90 Ag/ml trypsin for 3 h in the
presence or absence of 1% Triton X-100 to disrupt the
viral envelope. A replicate sample was incubated in the
absence of trypsin or detergent. The products were run on
a 12.5% polyacrylamide gel and subjected to Western blot
analysis.
Luciferase assay
NIH3T3 fibroblasts (6  105) were transfected using
Metafectene (Biontex Laboratories, Munich, Germany).
Twenty-four hours after transfection, the cells were split
into duplicate 60-mm dishes. The next day, the transfected
cells were infected with 5 PFU/cell of MCMV, with an
equal dilution of the same viral preparation that had been
UV inactivated, or mock infected. For the co-transfection
assays, the samples were mock infected. Samples were
harvested 24 h post-infection using Reporter Lysis Buffer
(Promega), and duplicate 20 Al samples were assayedusing the Luciferase assay system (Promega) in a 20/20
Luminometer (Turner Designs). Protein in the samples was
quantitated using the BCA protein assay kit (Pierce)
according to manufacturer’s directions and the luciferase
results were corrected for protein concentration. Samples
were assayed in duplicate in each experiment, and each
experiment was repeated at least five times.
Indirect immunofluorescence
IC-21 macrophages were used for these experiments
since they display less pronounced cytopathic effect. Two
well chamber slides were seeded with 2  105 IC-21 cells.
After 24 h, the cells were infected with 5 PFU/cell of
MCMV. Cells were fixed at various times after infection by
washing three times with PBS with 1 mM MgCl2 and 1.2
mM CaCl2 and incubation for 10 min with 2% paraformal-
dehyde in PBS. Cells were then washed three times with
PBS and permeabilized with 0.5% Triton X-100 in PBS.
After blocking in PBS with 5% normal goat serum, cells
were stained with primary antibody for 1 h at 37 8C and
with secondary goat-anti-mouse TRITC (Sigma), goat-anti-
rabbit FITC (Sigma), or AlexaFluor 647 goat-anti-rabbit
IgG (Molecular Probes, Eugene, OR). Cells were mounted
with Slowfade mounting medium (Molecular Probes) and
examined using a Zeiss 510 confocal microscope at 40 or
100 magnification.
CAT assay
NIH3T3 cells were transfected as described for the
luciferase assay. The plasmid pie111, expressing ie1m3,
was added at a concentration previously demonstrated to
result in less than maximal activation, to allow detection of
enhancement (data not shown). Forty-eight hours post-
transfection, cells were washed with Tris-buffered saline
(TBS, 30 mM Tris, 150 mM NaCl, pH 7.5) then harvested
by scraping in fresh TBS. Cells were pelleted and
resuspended in 0.25 mM Tris–HCl, pH 7.8 then lysed by
three rounds of freezing and thawing. Cellular debris was
pelleted and the supernatants were heated to 68 8C for 10
min prior to assaying. Protein concentrations were deter-
mined using the BCA protein assay kit (Pierce). CAT
assays were performed by standard methods, using 20 Al
of extract (Depto and Stenberg, 1989). After autoradiog-
raphy, quantitation was performed using Phosphorimager
analysis (Molecular Dynamics, Sunnyvale, CA). Experi-
ments were repeated at least 3 times. Results were
corrected for relative protein levels for quantitation.Acknowledgments
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